Search form

Robert Peabody Comments on the Aegerion Pharmaceuticals Drug Marketing Case

Robert Peabody comments on the recent sentence of Aegerion Pharmaceuticals Inc for improperly marketing a cholesterol drug in "Cambridge pharmaceutical company ordered to pay $7.2 million in restitution," published by the Boston Globe.

Subscription may be required to view article

 

Mentioned

Practices

People

See AllRelated News

July 27, 2018
IPWatchdog

Jackson Lewis Highlighted in Lex Machina's New Trade Secret Litigation Report

July 27, 2018

Jackson Lewis is highlighted in Lex Machina's first Trade Secret Litigation Report. The report encapsulates data sets and trend highlights occurring over a nine-year period from more than 9,800 cases brought under state trade secret laws and the federal Defend Trade Secrets Act (DTSA) of 2016 in "Reports Shows Significant... Read More

July 18, 2018
Law 360

Jackson Lewis Spotlighted in Lex Machina's New Trade Secret Litigation Report

July 18, 2018

Jackson Lewis is spotlighted in Lex Machina's first Trade Secret Litigation Report highlighting the law firms that both claimants and defendants most often turn to when a trade secret case arises in "Trade Secret Suits Rise Sharply In Wake Of Landmark IP Law," published by Law360.  Subscription ay be required to view article... Read More

July 11, 2018
Connecticut Law Tribune

Paul Kelly Discusses the Acquittal of a Maritime Technician in Theft Of Trade Secrets Trial

July 11, 2018

Paul Kelly discusses the recent split jury verdict in a theft-of-trade-secret case charging two defendants with conspiracy and theft of trade secrets. The jury found defendant Jay Williams, represented by Jackson Lewis, not guilty on all counts in "'Suspended Disbelief': Split Verdict in Theft of Trade Secrets Trial in Connecticut... Read More